{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T11:49:24Z","timestamp":1790509764884,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2004,10,2]],"date-time":"2004-10-02T00:00:00Z","timestamp":1096675200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1007\/s00228-004-0830-4","type":"journal-article","created":{"date-parts":[[2004,10,2]],"date-time":"2004-10-02T01:54:38Z","timestamp":1096682078000},"page":"651-658","source":"Crossref","is-referenced-by-count":140,"title":["The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals"],"prefix":"10.1007","volume":"60","author":[{"given":"Hege Salvesen","family":"Blix","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten K.","family":"Viktil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\ufffdsmund","family":"Reikvam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tron Anders","family":"Moger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bodil Jahren","family":"Hjemaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piia","family":"Pretsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tine Flindt","family":"Vraalsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elspeth K.","family":"Walseth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,10,2]]},"reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/jama.1997.03540280039031","volume":"277","author":"DC Classen","year":"1997","unstructured":"Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Bruke JP (1997) Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 277:301?306","journal-title":"JAMA"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1001\/jama.1997.03540280045032","volume":"277","author":"DW Bates","year":"1997","unstructured":"Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA, Small SD, Sweitzer BJ, Leape LL (1997) The costs of adverse drug events in hospitalized patients. Adverse drug events prevention study group. JAMA 277:307?311","journal-title":"JAMA"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S1086-5802(16)31229-3","volume":"41","author":"FR Ernst","year":"2001","unstructured":"Ernst FR, Grizzle AJ (2001) Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc (Wash) 41:192?199","journal-title":"J Am Pharm Assoc (Wash)"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s002280050738","volume":"56","author":"R Lagnaoui","year":"2000","unstructured":"Lagnaoui R, Moore N, Fach J, Longy-Boursier M, Begaud B (2000) Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability. Eur J Clin Pharmacol 56:181?186","journal-title":"Eur J Clin Pharmacol"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1345\/aph.1A225","volume":"36","author":"AG Winterstein","year":"2002","unstructured":"Winterstein AG, Sauer BC, Hepler CD, Poole C (2002) Preventable drug-related hospital admissions. Ann Pharmacother 36:1238?1248","journal-title":"Ann Pharmacother"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","volume":"279","author":"J Lazarou","year":"1998","unstructured":"Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: a meta- analysis of prospective studies. JAMA 279:1200?1205","journal-title":"JAMA"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1345\/aph.1A333","volume":"36","author":"PJ McDonnell","year":"2002","unstructured":"McDonnell PJ, Jacobs MR (2002) Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother 36:1331?1336","journal-title":"Ann Pharmacother"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1046\/j.1532-5415.2001.49042.x","volume":"49","author":"JT Hanlon","year":"2001","unstructured":"Hanlon JT, Schmader KE, Ruby CM, Weinberger M (2001) Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc 49:200?209","journal-title":"J Am Geriatr Soc"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1592\/phco.20.6.575.35163","volume":"20","author":"JT Hanlon","year":"2000","unstructured":"Hanlon JT, Fillenbaum GG, Schmader KE, Kuchibhatla M, Horner RD (2000) Inappropriate drug use among community-dwelling elderly. Pharmacotherapy 20:575?582","journal-title":"Pharmacotherapy"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1592\/phco.22.1.88.33503","volume":"22","author":"J Dhall","year":"2002","unstructured":"Dhall J, Larrat EP, Lapane KL (2002) Use of potentially inappropriate drugs in nursing homes. Pharmacotherapy 22:88?96","journal-title":"Pharmacotherapy"},{"key":"CR11","unstructured":"Norsk legemiddelh\u00e5ndbok for helsepersonell (2001) Oslo"},{"key":"CR12","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology (2002) ATC index with DDDs. WHO Collaborating Centre, Oslo"},{"key":"CR13","unstructured":"van Mil Consultancy (2002) Pharmaceutical care network Europe. DRP-classification V3.01"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1177\/106002809002401114","volume":"24","author":"LM Strand","year":"1990","unstructured":"Strand LM, Morley PC, Cipolle RJ, Ramsey R, Lamsam GD (1990) Drug-related problems: their structure and function. DICP 24:1093?1097","journal-title":"DICP"},{"key":"CR15","unstructured":"Spigset O, Krumsvik IL (2002) Legemiddelinteraksjoner. Felleskatalogen 1e-78"},{"key":"CR16","unstructured":"Hansten PD, Horn JR (2000) Drug interactions. Analysis and management. Facts and comparisons, St. Louis"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1086-5802(16)31244-X","volume":"41","author":"PD Hansten","year":"2001","unstructured":"Hansten PD, Horn JR, Hazlet TK (2001) ORCA: OpeRational ClassificAtion of drug interactions. J Am Pharm Assoc (Wash) 41:161?165","journal-title":"J Am Pharm Assoc (Wash)"},{"key":"CR18","unstructured":"Sj\u00f6quist F (2001) Interaktion mellan l\u00e4kemedel. I:FASS 2001. Stockholm:Linfo AS:1574?1653"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2796.1990.tb00199.x","volume":"228","author":"J Hallas","year":"1990","unstructured":"Hallas J, Harvald B, Gram LF, Grodum E, Brosen K, Haghfelt T, Damsbo N (1990) Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med 228:83?90","journal-title":"J Intern Med"},{"key":"CR20","first-page":"112","volume":"34","author":"J Venulet","year":"1996","unstructured":"Venulet J, TenHam M (1996) Methods for monitoring and documenting adverse drug reactions. Int J Clin Pharmacol Ther 34:112?129","journal-title":"Int J Clin Pharmacol Ther"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1001\/jama.1997.03540280050033","volume":"277","author":"TS Lesar","year":"1997","unstructured":"Lesar TS, Briceland L, Stein DS (1997) Factors related to errors in medication prescribing. JAMA 277:312?317","journal-title":"JAMA"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/00005650-199207000-00006","volume":"30","author":"HL Lipton","year":"1992","unstructured":"Lipton HL, Bero LA, Bird JA, McPhee SJ (1992) The impact of clinical pharmacists? consultations on physicians? geriatric drug prescribing. A randomized controlled trial. Med Care 30:646?658","journal-title":"Med Care"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1440-1762.2001.00428.x","volume":"21","author":"CP Alderman","year":"2001","unstructured":"Alderman CP, Farmer C (2001) A brief analysis of clinical pharmacy interventions undertaken in an Australian teaching hospital. J Qual Clin Pract 21:99?103","journal-title":"J Qual Clin Pract"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/ajhp\/54.4.397","volume":"54","author":"ND Barber","year":"1997","unstructured":"Barber ND, Batty R, Ridout DA (1997) Predicting the rate of physician-accepted interventions by hospital pharmacists in the United Kingdom. Am J Health Syst Pharm 54:397?405","journal-title":"Am J Health Syst Pharm"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S0002-9149(97)00060-X","volume":"79","author":"BA Bart","year":"1997","unstructured":"Bart BA, Gattis WA, Diem SJ, O?Connor CM (1997) Reasons for underuse of angiotensin-converting enzyme inhibitors in patients with heart failure and left ventricular dysfunction. Am J Cardiol 79:1118?1120","journal-title":"Am J Cardiol"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0002-8703(98)70180-2","volume":"136","author":"WA Gattis","year":"1998","unstructured":"Gattis WA, Larsen RL, Hasselblad V, Bart BA, O?Connor CM (1998) Is optimal angiotensin-converting enzyme inhibitor dosing neglected in elderly patients with heart failure? Am Heart J 136:43?48","journal-title":"Am Heart J"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0002-8703(00)90313-2","volume":"139","author":"G Gambassi","year":"2000","unstructured":"Gambassi G, Forman DE, Lapane KL, Mor V, Sgadari A, Lipsitz LA, Bernabei R (2000) Management of heart failure among very old persons living in long-term care: has the voice of trials spread? The SAGE study group. Am Heart J 139:85?93","journal-title":"Am Heart J"},{"issue":"6","key":"CR28","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/ageing\/31.6.435","volume":"31","author":"CA Oborne","year":"2002","unstructured":"Oborne CA, Hooper R, Li KC, Swift CG and Jackson SH (2002) An indicator of appropriate neuroleptic prescribing nursing homes. Age Ageing 31(6):435?439","journal-title":"Age Ageing"},{"issue":"10","key":"CR29","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/gerona\/55.10.M554","volume":"55","author":"JH Flaherty","year":"2000","unstructured":"Flaherty JH, Perry HM, Lynchard GS and Morley JE (2000) Polypharmacy and hospitalization among older home care patients. J Gerontol A Biol Sci Med Sci 55(10):554?559","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.5694\/j.1326-5377.2002.tb04730.x","volume":"177","author":"AL Gilbert","year":"2002","unstructured":"Gilbert AL, Roughead EE, Beilby J, Mott K, Barratt JD (2002) Collaborative medication management services: improving patient care. Med J Aust 177:189?192","journal-title":"Med J Aust"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/(SICI)1099-1166(199807)13:7<433::AID-GPS798>3.0.CO;2-9","volume":"13","author":"L Furniss","year":"1998","unstructured":"Furniss L, Craig SK, Burns A (1998) Medication use in nursing homes for elderly people. Int J Geriatr Psychiatry 13:433?439","journal-title":"Int J Geriatr Psychiatry"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1001\/archinte.162.15.1670","volume":"162","author":"JH Gurwitz","year":"2002","unstructured":"Gurwitz JH, Rochon P (2002) Improving the quality of medication use in elderly patients: a not-so- simple prescription. Arch Intern Med 162:1670?1672","journal-title":"Arch Intern Med"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1001\/archinte.1991.00400090107019","volume":"151","author":"MH Beers","year":"1991","unstructured":"Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC (1991) Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 151:1825?1832","journal-title":"Arch Intern Med"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0895-4356(94)90192-9","volume":"47","author":"GP Samsa","year":"1994","unstructured":"Samsa GP, Hanlon JT, Schmader KE, Weinberger M, Clipp EC, Uttech KM, Lewis IK, Landsman PB, Cohen HJ (1994) A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validity. J Clin Epidemiol 47:891?896","journal-title":"J Clin Epidemiol"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/bmj.320.7237.741","volume":"320","author":"EJ Thomas","year":"2000","unstructured":"Thomas EJ, Brennan TA (2000) Incidence and types of preventable adverse events in elderly patients: population based review of medical records. BMJ 320:741?744","journal-title":"BMJ"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/j.1532-5415.1991.tb02875.x","volume":"39","author":"P Carbonin","year":"1991","unstructured":"Carbonin P, Pahor M, Bernabei R, Sgadari A (1991) Is age an independent risk factor of adverse drug reactions in hospitalized medical patients? J Am Geriatr Soc 39:1093?1099","journal-title":"J Am Geriatr Soc"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-004-0830-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-004-0830-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-004-0830-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T07:40:40Z","timestamp":1585899640000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-004-0830-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10,2]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["830"],"URL":"https:\/\/doi.org\/10.1007\/s00228-004-0830-4","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10,2]]}}}